P lasma lipoproteins influence the development of atherosclerosis, and their concentrations are associated with the risk of coronary heart disease. 1 The genes for 3 apolipoproteins, apoA-I, apoC-III, and apoA-IV, are grouped together in a cluster on 17 kb of human chromosome 11. 2 ApoA-I is the major protein component of HDL. Through its ability to promote cholesterol efflux from cultured cells and to activate lecithin:cholesterol acyltransferase (LCAT), it is involved in reverse cholesterol transport (RCT). 1 Expression of the human apoA-I ( h apoA-I) gene decreases the development of fatty lesions in cholesterol-fed transgenic (Tg) mice 3 and in apoE-deficient (apoE Ϫ/Ϫ ) mice. 4 ApoA-I deficiency in mice did not increase atherogenesis in a normal background 5 but did so in hypercholesterolemic mice expressing human apoB. 6 ApoC-III is a component of HDL and triglyceride-rich lipoproteins (TGRLs). Plasma apoC-III concentration is positively correlated with triglyceride concentration. By inhibiting TGRL catabolism, apoC-III induces hypertriglyceridemia in Tg mice. 7 Expression of the gene was not atherogenic in apoE Ϫ/Ϫ mice. 8 In contrast, h apoC-III expression, in normal or in LDL receptor-deficient mice, resulted in increased atherosclerosis. 9, 10 ApoA-IV, involved in RCT-like apoA-I, 1 also has antiatherogenic properties, inasmuch as overexpression of apoA-IV reduced aortic lesions. 11, 12 The foregoing observations indicate that the apoA-I/C-III/A-IV gene cluster is of major interest in relation to atherogenesis.
A series of DNA elements seems to coordinately regulate the transcription of all 3 genes. [13] [14] [15] Indeed, analyses of intestinal mRNA levels have shown that the expression of the 3 genes is coregulated in this organ in vivo. 16 Tg mice have already been developed for apoA-I, 3, 13, 17 apoC-III, 8, 13, 18 and apoA-IV 11, 12, 19, 20 and have provided valuable information on the properties and functions of each gene in isolation. However, none of these animal models is suitable for studies of the effect of the coordinated expression of the 3 genes in combination. Moreover, new therapeutic agents that increase apoA-I concentration are currently being sought. Whether such agents will change the expression of the other genes of the cluster and produce an atherogenic or a nonatherogenic effect is not known. A model expressing the entire human apoA-I/C-III/A-IV cluster would be of considerable value for the investigation of its properties and functions as an integrated unit. In the present study, we report the generation and characterization of such Tg mice.
Methods Animals
The transgene was obtained from the DMPC-HFF#1-1412-B12 cosmid isolated from a human genomic library (DuPont Merck Pharmaceutical Co) screened for the presence of apoA-IV sequences by polymerase chain reaction. A 33-kb NotI/SalI fragment, containing 8.3 kb of the 5Ј region of apoA-I, the 17-kb entire apoA-I/C-III/ A-IV gene cluster, and 7.5 kb of the 3Ј region of apoA-IV, was microinjected into fertilized mouse eggs. Tg mice were identified by the presence of the 3 human genes. Three Tg lines were established in the C57Bl/6 genetic background (Tg11, Tg12, and Tg21). Transgene copy numbers were determined by Southern blotting. 20 Mice, housed in a temperature-controlled room with alternating 12-hour light (7:00 AM to 7:00 PM) and dark (7:00 PM to 7:00 AM) periods, had access to regular mouse chow and water ad libitum. All procedures involving animal handling and care were conducted in accordance with Pasteur Institute Guidelines for Husbandry of Laboratory Mice. Tg mice in an apoE Ϫ/Ϫ background were established by backcrossing Tg12 animals with apoE Ϫ/Ϫ mice. 21 For blood collection, food was removed from mice at 9:00 AM, and 8 hours later, samples were collected from the retro-orbital sinus into tubes containing Na 2 -EDTA (final concentration 5 mmol/L). Plasma was promptly separated from cells by centrifugation at 5000g at 4°C.
Northern Blot Experiments
After an overnight fast, the animals were killed by cervical dislocation, and tissues (liver, small intestine, spleen, kidney, lung, brain, and stomach) were removed. Total RNAs were extracted with RNA-plus (Quantum), purified, and electrophoresed (20 g total RNA per lane) on 1% agarose gels containing formaldehyde. Samples were blotted onto Hybond-N ϩ membranes (Amersham Pharmacia Biotech) and hybridized with 32 P-labeled cDNA probes, as previously described. 7, 11, 22 
Apolipoprotein Quantification
Human apolipoproteins were quantified by immunoelectrophoresis with specific polyclonal antibodies (Hydragels SEBIA); mouse apolipoproteins did not cross-react. Mouse plasma apoA-I concentrations were measured by immunonephelometry with the use of rabbit polyclonal antibodies. These antibodies showed no crossspecies reactivity. 23 Human apolipoproteins in high-performance-sized exclusion chromatographic (HP-SEC) fractions were quantified by liquidphase double-antibody-based radioimmunoassays, with the use of Tween 20 (0.2% [vol/vol] ) to expose cryptic epitopes and polyethylene glycol 8000 (3% [wt/vol]) to enhance reaction kinetics. The primary antisera were polyclonal IgG against delipidated human apolipoproteins (goat anti-apoA-I and goat anti-apoC-III, provided by International Immunology Corp; rabbit anti-apoA-IV 11 ) that displayed insignificant cross-reactivity with their mouse counterparts. Donkey anti-goat or donkey anti-rabbit IgGs were used as precipitating antibodies (Chemicon). Radioactivity in antibodybound pellets (1500g, 30 minutes, 4°C) was quantified to Ͻ0.1% counting error. Radioiodinated tracers were prepared by use of chloramine T treatment of either delipidated human apolipoproteins (A-I and C-III, Intracel Corp) or recombinant apoA-IV. All assays were standardized by using appropriate dilutions of the pure apolipoproteins. All plasma samples were analyzed in duplicate with coefficients of variation Ͻ12%.
ApoB 48 and apoB 100 were separated by SDS-PAGE in 4% to 15% gradient polyacrylamide PhastGels (Amersham Pharmacia Biotech). Gels were silver-stained, scanned, and analyzed by use of a video densitometer scanner and NIH image software. Analyses were repeated 3 times for each different group of animals.
Lipid and Lipoprotein Analyses
Lipoproteins were separated into density (d) fractions of dϽ1.006 g/mL, dϭ1.006 to 1.019 g/mL, and dϭ1.019 to 1.063 g/mL by sequential isopycnic ultracentrifugation with use of KBr to adjust densities. Each spin was carried out for 2 hours at 435 000g at 15°C in a fixed-angle rotor. 24 HP-SEC was used to separate lipoproteins according to size. Plasma aliquots (50 L) were chromatographed at ambient temperature through Superdex 200 and Superdex 75 columns connected in series (HR 10/30, Amersham Pharmacia Biotech). A solution of 50 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1 mg/mL sodium azide, and 1 mg/mL Na 2 -EDTA was used as eluant (pumped at 0.75 mL/min). After the void volume was excluded, 60ϫ225-L fractions were collected. Recoveries were always Ͼ90%. Apparent hydrated sizes of lipoprotein subclasses were evaluated by comparing their elution times with those of protein markers (Amersham Pharmacia Biotech).
HDL particle size and heterogeneity were evaluated by electrophoresing whole plasma in commercially available nondenaturing polyacrylamide gradient gels (Lipogel Lipoprotein Fractionation System, Zaxis Inc), according to the manufacturer's instructions. After electrophoretic separation for Ϸ1000 volts/hour in a Trisborate-EDTA buffer system, the distribution of neutral lipids was detected by staining with Sudan black B.
Nondenaturing 2D electrophoresis and Western blotting were performed as previously described. 25 After the 2 electrophoreses, lipoproteins were electrotransferred on to nitrocellulose membranes. The filters were immunodecorated with rabbit anti-mouse or antihuman apoA-I, apoC-III, or apoA-IV antibodies, followed by secondary peroxidase-labeled antibodies directed against rabbit IgG. The antisera directed against human or mice apolipoproteins were highly specific and did not show any cross-species reactivity, with the exception of the anti-mouse apoC-III, which recognized human apoC-III. Membranes were developed by use of a Chemiluminescence Western blotting detection kit (ECL System, Amersham Pharmacia Biotech). Experiments were repeated 3 times with samples from different control and Tg animals.
Triglyceride concentrations were determined by an enzymatic GPO-PAP method, and total and HDL cholesterol concentrations were determined by enzymatic CHOD-PAP methods with commercial kits (Boehringer-Mannheim). Precinorm L (BoehringerMannheim) was used as a calibrator.
Cholesterol Efflux and Esterification Studies
Cellular cholesterol efflux was determined with rat Fu5AH hepatoma cells incubated with 5% diluted serum. 23 Values are reported as the average of at least 3 different determinations. Purified human HDL samples were included in each assay as positive controls. LCAT activity was determined by use of the exogenous proteoliposome substrate method with 25 L of plasma from female mice. 23 Experiments were repeated twice with 3 and 5 different pools of samples for control and Tg mice, respectively (coefficient of variation Ͻ5%). Cholesterol esterification rate was determined as the decrease in unesterified cholesterol mass (measured enzymatically) during in vitro incubation of whole plasma at 37°C for periods up to 4 hours. Only female mouse plasma was analyzed, and all measurements were made in triplicate (coefficient of variation Ͻ1.5%).
Evaluation of Atherosclerotic Lesions
The spontaneous atherosclerosis model used in the present study was the apoE Ϫ/Ϫ mouse. 21 Fatty streak lesions were quantified by evaluating cross-sectional lesion sizes in the aortic sinus. 26 A randomly chosen subset of 10 Tg and 11 control female mice, both with the apoE Ϫ/Ϫ background, were euthanized at 20 weeks of age. Hearts and proximal aortas were removed, cleaned of pericardial fat, and fixed in PBS formalin solution (5%) for at least 48 hours. Then the hearts were cut directly under and parallel to the aortic leaflet, and the upper portions were embedded in Tissue-Tek O.C.T. compound (Sakura Finetek) and frozen at Ϫ80°C. Ten-micron-thick sections were cut through the aortic sinus, recognized by 3 valve cusps at the junction of the left ventricle and the aorta. Eighty sections per animal were stained for lipids with oil red O and counterstained with hematoxylin. Cross-sectional areas were analyzed by computerized planimetry. Statistical analysis was performed on 4 different crosssectional lesion areas per animal, separated by 160 m. The first section analyzed for each animal corresponded to the lower origin of the aortic sinus.
Statistical Analyses
Results are reported as meanϮSEM In all experiments non-Tg littermates were used as controls. Statistical differences in apolipoprotein and lipid levels between different groups of animals were evaluated by ANOVA. Other statistical differences were tested by the Student t test or Mann-Whitney U test for nonparametric analysis. Group differences or correlations with PϽ0.05 were considered statistically significant.
Results

ApoA-I/C-III/A-IV Transgene Expression
Tg mice were generated with a 33-kb human genomic fragment containing the entire cluster and flanking sequences. Three Tg lines, Tg11, Tg12, and Tg21 containing Ϸ9, 1, and 2 copies, respectively, of the transgene, were established. All Tg lines showed hepatic and intestinal expression of the 3 human genes (Figure 1 ). Human mRNA levels were higher in the liver than in the intestine. No expression was detected in other analyzed tissues, with the exception of traces of all 3 human mRNAs in the kidney, of h apoA-I mRNA in the brain, spleen, and stomach, and of h apoA-IV mRNA in the stomach (data not shown). Because apoA-IV expression was reported to be mainly intestinal in humans and in h apoA-IV Tg mice, we have compared by Northern blot analysis the mRNA levels in h apoA-IV Tg mice 20 with those in the cluster Tg mice. Although the hepatic levels were similar in both strains, the intestinal mRNA levels were 2.3-fold lower in the cluster Tg mice (15.5Ϯ3.2 arbitrary units for h apoA-IV Tg mice versus 6.6Ϯ4.8 arbitrary units for cluster Tg mice, PϽ0.05), suggesting intestinal downregulation in the latter.
Human Plasma Apolipoproteins
All 3 human apolipoproteins were present in plasma from each line, and their concentrations were higher in Tg males than in Tg females ( Table 1 ). The means in the different lines were very similar. Average h apoA-I levels ranged from 241 to 283 mg/dL, with an overall mean for the 3 lines of 257Ϯ9 mg/dL (nϭ47); average h apoC-III levels were between 4.8 and 8.8 mg/dL, with an overall mean of 7.1Ϯ0.5 mg/dL; and h apoA-IV concentrations averaged 0.8 to 1.4 mg/dL, with an overall mean of 1.0Ϯ0.2 mg/dL. The plasma concentration of h apoA-I was positively correlated with that of h apoC-III (rϭ0.67, PϽ0.001). Because of the low concentration of h apoA-IV, it was difficult to assess the strength of its association with the concentrations of h apoA-I or h apoC-III. 
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Mean plasma triglyceride and total cholesterol concentrations were higher in Tg males than in Tg females ( 
Lipid and ApoB Distributions in Lipoprotein Density Fractions
Lipoproteins were isolated by sequential ultracentrifugation from plasma samples from Tg mice of line 12 and control littermates. Increases of triglycerides and cholesterol in Tg mice were observed in lipoproteins of dϽ1.006 g/mL and dϭ1.006 to 1.019 g/mL (Figure 2A and 2B) . Analysis of apoB showed a major increase in total apoB 48 , whereas total apoB 100 remained unchanged. The apoB 48 increase in the Tg mice was detected in all fractions analyzed; in particular, an 11-fold increase was observed in particles of dϽ1.006 g/mL ( Figure 2C ). Although the total apoB 100 level remained unchanged, lipoprotein fraction analysis showed a significant decrease in the dϭ1.019 to 1.063 g/mL fraction in Tg mice ( Figure 2D) . Thus, the increases in triglycerides and cholesterol observed in Tg mice were due to an accumulation of apoB 48 -rich lipoproteins of dϽ1.006 g/mL. Similar results were obtained with mice from line 21.
Cholesterol and Apolipoprotein Distributions in Size Subclasses of Lipoproteins
The distributions of the cholesterol and human apolipoproteins in size subclasses of lipoproteins were analyzed by HP-SEC of whole plasma. Results for representative male and female animals are shown in Figure 3 . 
Human and Mouse Apolipoprotein Distribution in HDL Particles
In addition to the quantitative differences in non-HDL and HDL cholesterol between Tg and non-Tg animals demonstrated by precipitation assays, there were marked differences between the 2 groups in the number and sizes of HDL subpopulations analyzed in nondenaturing polyacrylamide gradient gels. An essentially monodisperse population of large HDLs present in the control mice was replaced by multiple HDL subspecies in the cluster Tgs, accompanied by a redistribution of core lipids into small HDLs ( Figure I , which can be accessed online at www.ahajournals.org).
Bidimensional electrophoresis and Western blotting with species-specific anti-apolipoprotein antisera (Figure 4) showed that h apoA-I was contained mostly in ␣-migrating particles and to a lesser degree in multiple pre-␤ particles. Mouse apoA-I was localized predominantly in ␣-HDL particles in control mice, whereas in Tg mice, it was reduced and distributed almost exclusively in pre-␤ HDL particles. This reduction in mouse apoA-I concentrations was consistent with the values measured in whole plasma by immunoassay (114Ϯ7 mg/dL in control mice versus 20Ϯ4 mg/dL in Tg mice, PϽ0.001). Mouse apoC-III in control mice and h apoC-III in Tg mice were localized mainly in ␣ particles. We did not localize mouse apoC-III in Tg mice, because antibodies directed against the mouse protein also recognized h apoC-III. Finally, human apoA-IV and mouse apoA-IV were localized only in pre-␤ HDLs. In Tg mice, mouse apoA-IV was displaced from certain pre-␤ HDL particles, presumably by h apoA-I. Thus, h apoA-I and h apoA-IV were able to form pre-␤ particles in these mice.
Cholesterol Efflux, LCAT Activity, and Cholesterol Esterification Rate
Plasma from Tg mice was 29% more efficient than plasma from non-Tg mice (12.4Ϯ0.8% versus 9.6Ϯ0.5%, respectively; PϽ0.05) in promoting cholesterol efflux from Fu5AH cells. Whereas no significant difference in plasma LCAT activity was observed between Tg and control mice (7.3Ϯ0.5 versus 6.6Ϯ0.4, respectively; Pϭ0.324), the plasma cholesterol esterification rate was reduced in the Tg mice ( Figure II , which can be accessed online at www.ahajournlas.org).
Expression of the Human ApoA-I/C-III/A-IV Gene Cluster in ApoE
؊/؊ Mice
Concentration of h apoA-I was significantly lower in an apoE null background (Tg12/apoE Ϫ/Ϫ ) than in the original background (Tg12). In Tg12/apoE Ϫ/Ϫ mice, the h apoC-III concentration was increased in males but not in females, and the h apoA-IV concentration was unchanged (Table 1 ). In this apoE Ϫ/Ϫ background, concentrations of human apolipoproteins were also higher in males than in females. There was a large increase in plasma triglycerides in Tg compared with control mice (Table 2) : an18-fold increase in males and a 7-fold increase in females. Total cholesterol, which was already very high in apoE Ϫ/Ϫ mice, was even more elevated in the Tg12/apoE Ϫ/Ϫ strain because of an increase in non-HDL and HDL fractions. Cholesterol efflux capacity and LCAT activity were both higher in apoE Ϫ/Ϫ mouse plasma than in the Tg12/apoE Ϫ/Ϫ mouse plasma (8.31Ϯ1.57% versus 6.14Ϯ1.10%, PϽ0.05, and 2.5Ϯ0.2 versus 1.
PϽ0.01, respectively). Previous studies have shown that the apoE
Ϫ/Ϫ mouse model develops atherosclerotic lesions spontaneously. 21 In the present study, all the control and cluster Tg mice with an apoE Ϫ/Ϫ background developed spontaneous lesions in the aortic sinus at 20 weeks of age. Characteristic sections from each group showed that the lesions were morphologically similar. However, the average cross-sectional areas of lesions were 61% lower in Tg12/apoE Ϫ/Ϫ mice than in apoE 
Discussion
To study the effect of the coordinated expression of the 3 genes of the apoA-I/C-III/A-IV cluster, we have created Tg mice with this human cluster. In the present study, we demonstrate that expression of the entire cluster in mice produces a hyperlipidemic profile but protects against atherosclerosis. 
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Regulatory regions of the 3 genes have been localized throughout the entire gene cluster, and all known regulatory elements were present in their natural positions in the genomic fragment used to generate the Tg animals. Northern blot analyses showed the presence of the 3 human mRNAs in the liver and intestine. These results suggest that the transgene contains all the regulatory regions required to direct a tissue-specific expression of the 3 genes. Hepatic and intestinal expressions of h apoA-I and h apoC-III were roughly similar to those observed in humans. 27 ApoA-IV expression was mainly hepatic, in contrast to the predominant intestinal expression observed in humans or in h apoA-IV Tg mice. 19, 20 Because the latter were generated with a DNA fragment contained within that used to generate the cluster Tg mice, the apoA-IV expression observed in the present study does not seem to be due to the absence of a DNA regulatory element. Comparison between intestinally expressing h apoA-IV Tg mice 20 and cluster Tg mice showed that hepatic mRNA levels were similar in both types of mice, whereas intestinal mRNA levels were much lower in the cluster Tg mice. We hypothesize that the overexpression of h apoA-I or h apoC-III genes or the subsequent alterations induced in the lipid profile might reduce intestinal apoA-IV expression in cluster Tg mice.
All Tg lines showed the presence of the 3 human apolipoproteins in plasma. The mean plasma concentrations of each human apolipoprotein were rather similar in the 3 lines, suggesting that their concentrations were precisely controlled in these animals. This control seems to be independent of transgene copy number, inasmuch as Tg11, Tg12, and Tg21 lines contained 9, 1, and 2 copies, respectively, of the transgene. The control also seems independent of the insertion site, inasmuch as the 3 lines were independently generated.
Concentrations of h apoA-I and h apoC-III in plasma were Ϸ2-fold greater than the values in humans. In contrast, much lower concentrations of h apoA-IV were detected in the cluster Tg mice, probably because of the low level of intestinal expression observed. Size exclusion chromatography demonstrated that most h apoA-I was present in particles of a size similar to that of cholesterol-rich HDLs in humans. Minor amounts of h apoA-I were present in larger particles as well as in small lipid-poor species. Human apoC-III and apoA-IV were found in cholesterol-rich HDLs and in the non-HDL fraction. A substantial proportion of h apoA-IV was also present in small lipid-poor subclasses. These profiles were very similar to those observed in normal humans. 28, 29 Analysis of the lipid profile of the Tg mice showed gross hypertriglyceridemia and a moderate increase in plasma cholesterol, mainly in the non-HDL fraction. This lipid profile and the changes in apoB 48 and apoB 100 concentrations in lipoprotein subclasses show that the major increases in plasma lipids in the Tg mice reflect an accumulation of apoB 48 -rich particles. The observed association between the triglyceride, cholesterol, and h apoC-III concentrations and the increase in apoB 48 suggest that the profound hyperlipidemia is a causal effect of h apoC-III. Despite a high expression of h apoA-I, the effect of h apoC-III appears to predominate. The correlations that we observed between h apoC-III, triglyceride, and non-HDL cholesterol concentrations on one hand and h apoA-I and HDL cholesterol concentrations on the other suggest that the variations in the lipid profiles are consequences of those in the human apolipoprotein concentrations. However, because human apoA-I and apoC-III were correlated with each other, caution should be exercised in interpreting the metabolic bases of these associations.
The large Tg colony that we obtained enabled the effects of sex on gene expression to be assessed. In all Tg lines, the males had higher concentrations of human apolipoproteins than did the females. Tg males also tended to have higher lipid concentrations than did Tg females. These results suggest that sex-specific factors act to regulate the metabolism of these 3 apolipoproteins. The present Tg mice may be a useful model to study differences between the sexes in the regulation of this human gene cluster.
Inasmuch as apoA-I and apoA-IV have been demonstrated to protect against atherogenesis 3, 11, 12 and apoC-III has been reported to be proatherogenic, 9,10 the effect on atherogenesis of the expression of the entire cluster was unpredictable. We found that expression of the human apoA-I/C-III/A-IV gene cluster in an apoE Ϫ/Ϫ background substantially reduced the development of aortic lesions. This finding shows that apoA-I and/or apoA-IV can protect against atherosclerosis even in the presence of severe hyperlipidemia. Both apolipoproteins participate in RCT and promote cholesterol efflux from cultured cells. 1, 23, 25 In a normal background, new populations of HDLs appeared in the cluster Tg mice. All the human apoA-IV and a proportion of human apoA-I migrated to the pre-␤ position. Efflux of radiolabeled cholesterol from Fu5AH hepatoma cells was greater to Tg than to non-Tg plasma. All these results suggest that RCT might be increased in these mice. The lower LCAT activity in Tg compared with control mice may have been related to an effect of h apoC-III, which others have shown can inhibit LCAT activity in the presence of an excess of apoA-I. 30 In Tg apoE Ϫ/Ϫ mice, cholesterol efflux and LCAT activity were reduced, but we cannot rule out the possibility that enhanced RCT is the basis of the protective mechanism. The extent to which the result of these in vitro assays, when applied to Tg apoE Ϫ/Ϫ sera, reflect the flux of cholesterol through the RCT pathway in vivo is uncertain. At least part of the resistance to atherosclerosis induced by cluster expression could have been attributable to properties of HDLs unrelated to their role in RCT, such as their ability to protect LDLs from oxidative modification 31 or to suppress adhesion molecule expression and induce cyclooxygenase-2 in vascular endothelium. 32 Associated changes in the concentration, size, and composition of apoBcontaining lipoproteins may also have contributed. Further work will be needed to clarify the mechanism(s) of the antiatherogenic effect of human cluster expression in mice. These apoA-I/C-III/A-IV Tg mice should be of value in the search for pharmacological agents that selectively act on the expression of the 3 human genes. 
